Improved glycaemic control with addition of NovoMix® 30 vs. metformin
{"Image DocumentName": "Improved glycaemic control with addition of NovoMix\u00ae 30 vs. metformin", "Image ImageDescription": "GLI+ NovoMix\u00ae 30. GLI+ NovoMix\u00ae 30. GLI+MET. GLI+MET \u20130.5. \u20130.3. \u20131.0. \u20131.5. Mean glucose reduction. (mmol/l) \u20130.6. \u20132.0. HbA1c reduction (%) \u20130.9. \u20132.5. BIAsp The overall (derived from the daily 7-point profiles) mean blood glucose change was greater for those treated with GLIB + NovoMix 30 than those with GLIB + MET; -2.85mmol/l vs mmol/l, p = The reduction in HbA1c was numerically greater when NovoMix 30 was added to glibenclamide compared with when metformin was added (-1.4% vs. -0.8%; p=NS) \u20133.0. \u20131.2. \u20133.5.   p < \u20134.0. \u20131.5. Raz I et al. Submitted to Diabetes, Obesity and Metabolism.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}